Wave Life Sciences Ltd.

NASDAQ: WVE · Real-Time Price · USD
9.77
0.86 (9.65%)
At close: Aug 15, 2025, 3:59 PM
9.80
0.36%
After-hours: Aug 15, 2025, 06:46 PM EDT

Wave Life Sciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
8.7M 9.18M 83.75M -7.68M 19.69M 12.54M 29.06M 49.21M 22.11M 12.93M 1.24M 285K 375K 1.75M 1.76M 36.42M 2.78M n/a
Cost of Revenue
n/a n/a n/a n/a n/a n/a 2.18M 2.26M 2.32M 2.44M 2.5M 2.6M 29.73M 27.47M 25.76M 31.09M 31.64M 2.46M
Gross Profit
8.7M 9.18M 83.75M -7.68M 19.69M 12.54M 26.87M 46.95M 19.78M 10.49M -1.26M -2.32M -29.36M -25.72M -24M 5.34M -28.86M -2.46M
Operating Income
-52.76M -49.8M 22.97M -63.91M -35M -34.46M -18.68M 4.44M -23.47M -30.29M -43.56M -38.9M -42.16M -38.09M -36.11M -7.61M -39.83M -43.47M
Interest Income
2.37M 2.88M n/a n/a n/a 2.54M n/a 1.96M 2.25M n/a n/a 596K n/a n/a n/a n/a n/a n/a
Pretax Income
-50.47M -46.88M 29.25M -61.78M -32.92M -31.56M -16.26M 6.58M -21.1M -27.41M -43.03M -39M -41.3M -37.81M -34.99M -6.23M -38.77M -42.46M
Net Income
-50.47M -46.88M 29.25M -61.78M -32.92M -31.56M -16.26M 7.25M -21.1M -24.52M -43.71M -39.11M 124K -37.53M -34.78M -6.23M -38.77M -42.46M
Selling & General & Admin
17.99M 18.36M 16.14M 15.04M 14.3M 13.55M 13.66M 13.13M 12.27M 12.23M 13.72M 11.61M 12.81M 12.37M 12.11M 12.94M 10.97M 10.08M
Research & Development
43.47M 40.62M 44.65M 41.2M 40.39M 33.45M 34.07M 31.64M 33.31M 30.98M 31.08M 27.57M 29.73M 27.47M 25.76M 31.09M 31.64M 33.39M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a 171K 118K 1.01M -290K -701K 744K 254K 1.12M 1.37M 1.05M 996K
Operating Expenses
61.46M 58.98M 60.78M 56.24M 54.69M 47M 47.74M 44.77M 45.58M 43.21M 44.8M 39.18M 42.54M 39.84M 37.88M 44.03M 42.6M 43.47M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 105K n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
61.46M 58.98M 60.78M 56.24M 54.69M 47M 47.74M 44.77M 45.58M 43.21M 44.8M 39.18M 42.54M 39.84M 37.88M 44.03M 42.6M 43.47M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a 677K n/a -2.88M 681K 105K -41.42M -280K -204K -6K -8K -11K
Shares Outstanding (Basic)
163.99M 162.53M 161.49M 131.45M 129.53M 129.27M 109.63M 106.03M 105.46M 102.06M 93.99M 92.87M 66.48M 60.52M 57.01M 50.71M 49.97M 49.1M
Shares Outstanding (Diluted)
163.99M 162.53M 172.29M 132.56M 129.53M 129.27M 109.63M 106.98M 105.46M 102.06M 93.99M 93.9M 66.48M 60.52M 57.19M 50.71M 49.97M 49.1M
EPS (Basic)
-0.31 -0.29 0.18 -0.47 -0.25 -0.24 -0.15 0.07 -0.2 -0.24 -0.47 -0.42 0.00 -0.62 -0.61 -0.12 -0.78 -0.86
EPS (Diluted)
-0.31 -0.29 0.17 -0.47 -0.25 -0.24 -0.15 0.07 -0.2 -0.24 -0.47 -0.42 0.00 -0.62 -0.61 -0.12 -0.78 -0.86
EBITDA
-50.56M -47.64M 25.12M -61.76M -32.83M -32.28M -16.5M 6.71M -21.15M -27.85M -40.53M -36.4M -38.79M -35.3M -32.45M -5.21M -36.33M -40M
EBIT
-52.76M -49.8M 22.97M -63.91M -35M -34.46M -18.68M 4.44M -23.47M -30.29M -43.56M -38.9M -42.16M -38.09M -36.11M -7.61M -39.83M -43.47M
Depreciation & Amortization
2.2M 2.16M 2.16M 2.16M 2.17M 2.18M 2.18M 2.26M 2.32M 2.44M 2.5M 2.6M 2.5M 2.51M 2.54M 2.4M 2.44M 2.46M